Anaptysbio (ANAB) Other Non Operating Income (2016 - 2026)
Anaptysbio (ANAB) posted Other Non Operating Income of -$1000.0 for Q1 2026, up 66.67% on a QoQ basis from -$3000.0 in Q4 2025, and down 100.05% year-over-year from $1.9 million in Q1 2025.
Anaptysbio (ANAB) Other Non Operating Income (2016 - 2026) Analysis & Trends
Anaptysbio's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 100.05% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 83.89% YoY) and the FY2025 annual result came in at $5.4 million, up 38685.71% from the prior year.
- Other Non Operating Income was -$1000.0 for Q1 2026 at Anaptysbio, up from -$3000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.5 million in Q2 2025 and bottomed at -$5000.0 in Q3 2024.
- A 5-year average of $553000.0 and a median of $3000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income slumped 600.0% — and 2025, when it soared 95200.0%.
- Anaptysbio's Other Non Operating Income stood at -$4000.0 in 2022, then soared by 71100.0% to $2.8 million in 2023, then plunged by 99.26% to $21000.0 in 2024, then plunged by 114.29% to -$3000.0 in 2025, then surged by 66.67% to -$1000.0 in 2026.
- Business Quant data shows ANAB's Other Non Operating Income at -$1000.0 in Q1 2026, -$3000.0 in Q4 2025, and $3.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Jun 30, 2025 | 3.53 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | -75,000.00 |
| Sep 30, 2020 | -56,000.00 |